Survival algorithms and outcome analysis in primary biliary cirrhosis

被引:15
作者
Pasha, TM [1 ]
Dickson, ER [1 ]
机构
[1] Mayo Clin & Mayo Fdn, Div Gastroenterol, Rochester, MN 55905 USA
关键词
survival; outcomes; primary biliary cirrhosis;
D O I
10.1055/s-2007-1007193
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The natural history of primary biliary cirrhosis (PBC) is one of slowly progressive cholestasis with liver damage, development of cirrhosis with its concomitant complications, and death unless the patient undergoes liver transplantation Natural history studies have identified several variables associated with a decreased survival in patients with PBC. The course of the disease can be divided into three time periods: (1) a presymptomatic phase, probably lasting up to 20 years; (2) a symptomatic phase, with anicteric or mild jaundice, lasting up to 5 to 10 years, and (3) a preterminal or accelerated phase with marked jaundice, lasting up to 2 years. Since the course of the disease is one of slow progression leading to liver failure and death unless liver transplantation intervenes, several investigators have developed statistical models to predict survival. The ability to predict survival for individual patients with PBC has been valuable in the management of these patients, particularly in patient selection and timing of liver transplantation In addition, survival estimates can be utilized in educating and counseling patients and their families. These models may also be used to evaluate the efficacy of new treatments by comparing natural history survival with the survival achieved by therapeutic effect. Over the past several decades, the natural history models of PBC have been developed in the absence of effective medical therapy. The efficacy of liver transplantation and survival following liver transplantation has now been quantitatively established. Future efforts should be aimed at determining not only survival of patients with primary biliary cirrhosis in the presence of effective medical therapy but also at assessing the quality of life and cost-effectiveness of medical therapy and liver transplantation in the management of patients with primary PBC.
引用
收藏
页码:147 / 158
页数:12
相关论文
共 50 条
  • [31] Autoimmunity and primary biliary cirrhosis
    Mackay, IR
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2000, 14 (04) : 519 - 533
  • [32] Primary biliary cirrhosis and pregnancy
    Ducarme, G.
    Bernuau, J.
    Luton, D.
    JOURNAL DE GYNECOLOGIE OBSTETRIQUE ET BIOLOGIE DE LA REPRODUCTION, 2014, 43 (05): : 335 - 341
  • [33] Etiopathogenesis of primary biliary cirrhosis
    Ana Lleo
    Pietro Invernizzi
    M Eric Gershwin
    Ian R Mackay
    Harry Prince
    World Journal of Gastroenterology, 2008, (21) : 3328 - 3337
  • [34] Management of primary biliary cirrhosis
    Cynthia Levy
    Keith D. Lindor
    Current Treatment Options in Gastroenterology, 2003, 6 (6) : 493 - 498
  • [35] Women and Primary Biliary Cirrhosis
    Sun, Ying
    Haapanen, Krista
    Li, Baosen
    Zhang, Weici
    Van de Water, Judy
    Gershwin, M. Eric
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2015, 48 (2-3) : 285 - 300
  • [36] Etiopathogenesis of primary biliary cirrhosis
    Lleo, Ana
    Invernizzi, Pietro
    Mackay, Ian R.
    Prince, Harry
    Zhong, Ren-Qian
    Gershwin, M. Eric
    WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (21) : 3328 - 3337
  • [37] Infection and Primary Biliary Cirrhosis
    Agmon-Levin, Nancy
    Katz, Bat-sheva Porat
    Shoenfeld, Yehuda
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2009, 11 (02): : 112 - 115
  • [38] Malignancies in primary biliary cirrhosis
    Piscaglia, Fabio
    Sagrini, Elisabetta
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2008, 20 (01) : 1 - 4
  • [39] Primary Biliary Cirrhosis and the Microbiome
    Quigley, Eamonn M. M.
    SEMINARS IN LIVER DISEASE, 2016, 36 (04) : 349 - 353
  • [40] Cytokines in primary biliary cirrhosis
    Berg, PA
    Klein, R
    Röcken, M
    SEMINARS IN LIVER DISEASE, 1997, 17 (02) : 115 - 123